Mechanisms of neuronal cell injury/death and targets for drug intervention

被引:22
作者
Boxer, PA
Bigge, CF
机构
[1] Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor
关键词
D O I
10.1016/S1359-6446(97)01045-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The loss of neurons is responsible for many acute neurological disorders, as well as many chronic neurodegenerative diseases. Drug discovery research has concentrated on blocking necrosis produced by activation of one or more excitatory amino acid (EAA) receptors. Both receptor antagonists and compounds reducing EAA release are currently in clinical trials. With the recent advances in the understanding of apoptosis new strategies for neuroprotection are also emerging. It is anticipated that clinically useful neuroprotective drugs will soon be available for treatment of a range of CNS disorders, This article reviews some of the mechanisms responsible for neuronal cell death and outlines strategies to block calcium overload and free radical production.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 105 条
  • [1] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [2] EVALUATION OF THE REINFORCING EFFECTS OF ELIPRODIL IN RHESUS-MONKEYS AND ITS DISCRIMINATIVE STIMULUS EFFECTS IN RATS
    BALSTER, RL
    NICHOLSON, KL
    SANGER, DJ
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1994, 35 (03) : 211 - 216
  • [3] NEUROTRANSMITTER RECEPTORS .2. AMPA AND KAINATE RECEPTORS
    BETTLER, B
    MULLE, C
    [J]. NEUROPHARMACOLOGY, 1995, 34 (02) : 123 - 139
  • [5] SYNTHESIS OF 1,4,7,8,9,10-HEXAHYDRO-9-METHYL-6-NITROPYRIDO[3,4-F]-QUINOXALINE-2,3-DIONE AND RELATED QUINOXALINEDIONES - CHARACTERIZATION OF ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (AND N-METHYL-D-ASPARTATE) RECEPTOR AND ANTICONVULSANT ACTIVITY
    BIGGE, CF
    MALONE, TC
    BOXER, PA
    NELSON, CB
    ORTWINE, DF
    SCHELKUN, RM
    RETZ, DM
    LESCOSKY, LJ
    BOROSKY, SA
    VARTANIAN, MG
    SCHWARZ, RD
    CAMPBELL, GW
    ROBICHAUD, LJ
    WATJEN, F
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (19) : 3720 - 3740
  • [6] BOLANOS JP, 1995, J NEUROCHEM, V64, P1965
  • [7] BOXER PA, 1990, STROKE, V21, P47
  • [8] Neural apoptosis
    Bredesen, DE
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (06) : 839 - 851
  • [9] Strategies for neuroprotection with glutamate antagonists - Extrapolating from evidence taken from the first stroke and head injury studies
    Bullock, R
    [J]. NEUROPROTECTIVE AGENTS: CLINICAL AND EXPERIMENTAL ASPECTS, 1995, 765 : 272 - 278
  • [10] APOPTOSIS AND INCREASED GENERATION OF REACTIVE OXYGEN SPECIES IN DOWNS-SYNDROME NEURONS IN-VITRO
    BUSCIGLIO, J
    YANKNER, BA
    [J]. NATURE, 1995, 378 (6559) : 776 - 779